Several previous studies uncovered that CD4+ T cells can help cytotoxic T lymphocyte (CTL) activity via the enhancement of migratory and invasive potential, differentiation, and survival, expansion of CTLs, or enhancement of CTL activity [52], which suggest that CD4+ TRM cells might also have a beneficial role in the tumor killing. The gene discussed is CD4; the disease is neoplasm.